Introduction
Angelman syndrome (AS) is a genetic disorder with an incidence of 1 in 15,000, and it was first described in 1965 by Harry Angelman (1,2). It is characterized by a severe developmental delay together with mental disorders, movement disorders and behavioral abnormalities. Early severe epilepsy, sleep alteration, ataxia, important gait, absence of language and craniofacial dysmorphism are phenotypic characteristics used as diagnostic criteria of AS (3).
Several genetic mechanisms are known to associate with the development of Angelman syndrome including the deletion of 4 Mb region in chromosome 15q11-13, uniparental disomy (UPD), imprinting centre defects, and mutation in UBE3A (4) . The loss of expression of imprinted genes causes multiple human genetic disorders, including AS and Prader-Willi syndrome (PWS). Although these two diseases are associated with the lack of gene expression from the same chromosome 15q11-q13 region, the clinical features of the two disorders are distinct. Deletion or loss of paternally inherited gene expression results in PWS, while loss of maternally inherited gene expression causes AS (4) .
Multiple mouse models have been developed for the study of AS (Table 1 ). The first reported AS mouse model generated was a mouse with paternal UPD for chromosome 7 (5), followed by another mouse model generated by radiation-induced deletion of p locus and Ube3a (6) . However, these two models carried a large deletion of mouse chromosome 7C that could affect multiple loci (1). In the current study, we used a mouse model which carried an exon 2 deletion of the Ube3a gene resulting in a shift in the reading frame, thereby inactivating all putative isoforms of Ube3a (7) . If the offspring mice inherited the mutated Ube3a allele of maternal origin, the mice will have no Ube3a expression in the cerebellum, Purkinje cells and hippocampus, as Ube3a on the paternal chromosome is silenced by genomic imprinting. This mouse model exhibits symptoms similar to that of Angelman syndrome patients, including motor dysfunction, seizures, context-dependant learning deficiency and severely impaired long-term potentiation (LTP) (7) .
Several proteins that are involved in REDOX (oxidation-reduction reactions) were identified in the 2-D DIGE, including LDH, MDH, GSTs-Mu1, SOD2, and ATP5a1. The result suggested that loss of Ube3a may lead to mitochondrial dysfunction. In addition, the accumulation of Chaperone protein Hsp70 was observed and mRNA levels remained unchanged, suggesting that Hsp70 might be a substrate of Ube3a. Furthermore, NSF, which is known to be involved in neuronal signal transmission, was reduced at protein levels but unaffected at mRNA levels. Finally, CaBP is responsible for binding free calcium ions and may play an inductive role in seizures observed in AS mouse models and patients. TPI1, Triosephosphate isomerase 1, is one of the key enzymes in the glycolysis pathway, while CFL1, Cofilin 1, is known to be a potent regulator of actin filament dynamics. It remains to be determined how differential expression of these proteins may contribute to the development of AS.
Mutation
Phenotype Reference 1 Ube3a exon 2 deletion AS (7) 2 LacZ insertion inactivation of Ube3a
AS (8) 3 insertion/duplication located 13 kb upstream of Snrpn exon 1 AS imprinting mutation (9) 4 80-kb deletion located upstream of Snrpn exon 1 AS imprinting mutation (9) 5 Ube3a-Gabrb3 -Atp10a deletion AS (10) and Cy5 for the labelling of wild type and diseased samples prevented labelling bias. In the labelling reaction, the ratio of "dye: protein" was kept low to ensure optimal labelling efficiency. 
1-D isoelectric focusing

2-D gel electrophoresis
The 
Mouse genotyping
Three primers named oIMR1965, oIMR1966 and oIMR1967 were used to determine the genotype of the mouse. Primer oIMR1965 was the common primer; when it paired with primer oIMR1966, a 700 bp fragment from the wild type allele would be amplified. On the other hand, when primer oIMR1965 paired with primer oIMR1967, a 320 bp fragment from mutant allele would be amplified. The PCR cycling condition was heat activation at 95ºC for 3 min, followed by 40 cycles of 95ºC for 30 s, 67ºC for 1 min and 72ºC for 1 min; the final extension step was done at 72ºC for 2 min. The PCR product was analyzed by electrophoresis on 1.5% agarose gel.
Real time RT-PCR
The reaction was performed using iTaq TM SYBR ® Green Supermix with ROX (Cat. No. 172-5850, Bio-Rad) containing 2X reaction buffer, 0.4 mM dATP, 0.4 mM dCTP, 0.4 mM dGTP, 0.8 mM dUTP, iTaq DNA polymerase, 6 mM Mg +2 , SYBR Green I dye, 1 µM ROX internal reference dye and stabilizers. Reaction volume used was 25 µl, including 12.5 µl of 2X SYBR ® Green Supermix, 1 µl of synthesized cDNA, 1 µl of 10 µM forward primer, 1 µl of 10 µM reverse primer [ Table 2 ], topping up with nuclease free water.
Cycling was performed on 7500 Real Time RT-PCR system (Applied Biosystem). Cycling conditions were machine warm up at 50ºC for 2 min, hot initiation at 95ºC for 10 min, cycling condition (45 cycles) of 95ºC for 30 s, 60ºC for 30 s and 72ºC for 2 min, followed by a dissociation stage to generate a melting curve. ΔΔCT method was employed to calculate the differential expression of mRNA in samples examined, by comparing cycling results between target gene and basal control Glyceraldehyde-3-phosphate dehydrogenase (GADPH).
Name Sequence 1:2500-5000 Table 3 . Antibodies used in experiments
Results
In this project, the effects of the loss of UBE3A proteins were investigated using Ube3a knockout mice. Two-D DIGE method [ Figure 1 ] was used to identify candidate substrates of Ube3a in the cerebellum and hippocampus; a total of 94 proteins and 74 proteins were initially found differentially expressed in the cerebellum or hippocampus of the Ube3a knockout mice, respectively. Next, the protein candidates were tested with the following filtering criteria: 1) proteins appeared in all 2-D DIGE runs examined and 2) the one-way Analysis of Variance (ANOVA) compared protein expression level between the wild type and AS mice indicating the difference is statistically significant. The differentially expressed proteins were then identified by MALDI-TOF with a threshold score of 63. A total of 10 proteins that were successfully identified and fulfilled the filtering criteria are listed in Table 4 . An additional 4
www.intechopen.com proteins, including Mash1, NeuroD, Pax6 and VDR, were not detected in 2-D DIGE runs but were investigated in this project due to the fact that these proteins were shown to be h i g h l y a s s o c i a t e d w i t h o n e o f t h e p r o t e i n s i d e n t i f i e d i n t h i s p r o j e c t , C a B P ( 1 4 ) . Differentially expressed proteins identified by the 2-D DIGE could be due to the direct, indirect or both direct and indirect effects from the loss of Ube3a expression. Ube3a is known to be involved in proteasome-dependent as well as proteasome-independent functions. Therefore, Western blot analysis was performed to verify the differentially expressed proteins identified by 2-D DIGE analysis and further studied at the mRNA level by Real-Time RT-PCR. It helps to understand that these protein candidates may be affected at the protein level due to impaired protein degradation mechanism (4). Alternatively, these proteins may be affected at the transcriptional level, as Ube3a is also involved in transcriptional regulation (15) . 
2-D DIGE and silver staining
After the Decyder software analysis was performed by using analytical gel (CyDye labelled), another set of protein electrophoresis (preparative gel) were performed using 600 µg of unlabelled protein sample. The protein samples used in the preparative gel were the same as those used for 2-D DIGE analysis. After electrophoresis, silver staining was conducted to visualize protein spots on the gel. Typically, 800-1000 protein spots were visualized on each gel [ Figure 2 ]. Fig. 2 . Silver staining of acrylamide gel after SDS-electrophoresis Protein extract (600 µg) from cerebellum was loaded in a first dimension IPG strip (pH3-11, NL, 24 cm; Running time: 15.5 hr, approx 47 kVh) and resolved in 12.5% acrylamide gel (Running time: 5.15 hr, 10 W per gel). Proteins were visualized by silver staining. These gels are called preparative gels, and they contain more protein content to allow for subsequent analyses including silver staining and MALDI-TOF. CyDye labelled proteins were run on analytical gels which are scanned by lasers and thus do not require a high quantity of proteins.
Detection and identification of differentially expressed protein in AS versus wild type brain tissue
A total of ten differentially expressed proteins were detected by using 2-D DIGE from protein samples extracted from the cerebellum or hippocampus of wild type mice and AS mice (Ube3a knockout). The protein spots were recovered from silver-stained acrylamide gels run in parallel, and identification was made based on the protein profile generated by MALDI-TOF [ Figure 3 ] with a threshold score of 63. All candidates were confirmed at least twice in separate 2-D DIGE runs and MALDI-TOF identification. Another four bHLH proteins, including Mash1, NeuroD, Pax6 and VDR, were also studied in this project, as the proteins are highly related to CaBP (14) .
A total of eight proteins studied are involved in REDOX reactions, including HSP70, SOD2, MDH, LDH, VDR, GSTs-Mu1, ATP5a1 and CaBP. Four of the bHLH proteins, VDR, Pax6, Mash1 and NeuroD are involved in neuronal cell differentiation, while NSF is crucial in synaptic vesicle transmission and learning processes that are controlled by the hippocampus [ Figure 4 ]. TPI1 is involved in energy production, while Cofilin 1 is involved in actin disassembly and may also be involved in neuronal signal transduction. Fig. 3 . Protein identification by MALDI-TOF MS spectrum for one of the proteins identified-CaBP. After peptide detection, the peptide profile was used to match the NCBI database for protein identification. 
Validation of 2-D DIGE/MS results by Western blot analysis
Western blot was conducted to validate the differentially expressed proteins that were identified in 2-D DIGE/MS. In the cerebellum, three proteins, including SOD2, CaBP and Mash1, were down-regulated in Ube3a knockout mice [ Figure 5 ], while Hsp70, NSF and NeuroD were accumulated in knockout mice [ Figure 6 ]. However, SOD2, Mash1, CaBP, NeuroD and NSF were down-regulated [ Figure 7 ] and HSP70 was accumulated [ Figure 8 ] in the hippocampus of Ube3a knockout mice. The Western blots were repeated at least three times by using different sets of cerebellum and hippocampus tissues [ Figures 5-8 ].
In the cerebellum, Hsp70 was found to be up-regulated by approximately 120% based on the densitometer scan results. NSF and NeuroD were up-regulated by 85% and 50%, respectively. SOD2 was down-regulated by 45% in the cerebellum of Ube3a knockout mice. Based on densitometer scan results, CaBP and Mash1 were both found to be reduced by approximately 75% in defective mice.
In the hippocampus, Hsp70 was increased by 50% when samples from wild type mice were compared to defective mice. SOD2 and Mash1 were both reduced by approximately 80% in Ube3a knockout mice; CaBP and NeuroD were found down-regulated by 40% and 45%, respectively, when compared to the wild type sample. Lastly, NSF was reduced by nearly 50% in Ube3a knockout mice. The major differences in the Western blot validation are the differential expressions of NeuroD and NSF in these two tissues. These two proteins were found to be up-regulated in the cerebellum but down-regulated in the hippocampus [ Figure 9 ]. This suggests that the expression of these two proteins might be tissue specific. Western blot analysis for protein candidates VDR, LDH, MDH, GSTs-Mu1 and ATP5a1 has not been conducted due to the unavailability of antibodies when this study was conducted. Fig. 9 . A summary of the validation of 2-D DIGE/MS results by Western blot analysis. A total of 6 proteins from the cerebellum and hippocampus were tested by Western blot. Three of them, including CaBP, Nash1 and SOD2, were down-regulated and one (Hsp70) was upregulated in both tissues, while both NSF and NeuroD showed tissue-specific expression patterns.
Transcriptional analysis of the differentially expressed proteins verified by Western blot analysis
Since variation of steady state protein level between wild type and mutant mice can be caused by enhancing transcriptional activity instead of enhancing protein half life, Real Time RT-PCR was conducted to quantify mRNA levels of proteins detected by 2-D DIGE. mRNA extracted from the cerebellum and hippocampus of wild type mice as well as Ube3a knockout mice were used in this study. Real Time RT-PCR was conducted at least three times for individual sets of mice. The Student's T-test was applied for this study.
Based on results of Real Time RT-PCR obtained from the cerebellum sample [ 
Discussion
When Ube3a was first identified as an E3 ligase, little was known about its targeting substrates besides p53 (1). However, as techniques improved over the years, additional substrates of Ube3a were identified [ Among these proteins, Blk, from the tightly regulated Src family of non-receptor tyrosine kinase, is important in cytoskeletal organization, cell-cell contact, and cell-matrix adhesion; a few other proteins from the Src family are also interacting partners of Ube3a (16) . Cystic fibrosis transmembrane regulator-associated ligands (CAL), which serve as membrane-associated scaffolds, are involved in the targeting of other plasma membrane proteins and autophagy in neuronal cells (17) . Trihydrophobin 1 (TH1) is another interacting partner and target of Ube3a that was recently identified; it is an integral subunit of the human negative transcription elongation factor (NELF) complex, which is important in transcriptional pausing in vitro (18) . ECT2 is involved in cytokinesis and cytoskeletal remodelling in response to all known neurite guidance cues (19) . Its dysregulation may explain the general learning and behaviour defects in AS patients (4). Polyglutamine inclusion, which is translated from the expansion of a CAG trinucleotide repeat, causes several human neurodegenerative diseases, including spino-bulbar muscular atrophy (SBMA), Huntington's disease (HD) and the spinocerebellar ataxias (20) (21) (22) .
In this study, we intended to examine the differential expression of proteins caused by the knockout of Ube3a in the AS model. By 2-D DIGE/MS, we identified proteins that are differentially expressed in the mutant mice, which may serve as the target substrates of Ube3a. The accumulation or reduction of these proteins may correlate with the phenotypes observed among AS patients.
From our 2-D DIGE/MS experiment and Western blot analysis using cerebellum [ Figure 6 ] and hippocampus [ Figure 8 ] tissue samples, up-regulation of Hsp70 was observed in Ube3a knockout mice. However, Real-Time RT-PCR analysis [ Table 5 ] using RNA samples extracted from mice showed that Hsp70 mRNA levels were not significantly affected in the cerebellum and hippocampus when comparing Ube3a knockout and wild type mice. In conclusion, the differential expression of Hsp70 was observed only at the translational or protein level. It is conceivable that Hsp70 is the target of Ube3a, as Hsp70 is a multifunctional protein; its most prominent task is to serve as a chaperone in the ubiquitin proteasome system. Parkin and CHIP are two other E3-ligases that are known to interact with Hsp70 for protein quality control tasks (21) . To perform its quality control task, Hsp70 serves as a chaperone that binds to misfolded proteins during translation or after stressmediated protein damage. Studies have shown that Hsp70 interacts with co-chaperone CHIP, which functions as a RING domain E3-ligase, and together they serve as the protein quality control system that clears stress-damaged proteins from cells. Such proteins include tau in Alzheimer's disease and expanded polyglutamate protein in Huntington's disease (23, 24) . A recent study also demonstrated that E6AP reduces polyglutamate protein aggregation, which induces cell death. Results also showed that E6AP is over-expressed correlated with HSP70. The author suggested that HSP70 may play a modulatory role on the function of E6AP (20) . Another study has also shown that Hsp70 is degraded through CHIPdependent targeting to the ubiquitin-proteasome system (21) . If E6AP does interact with Hsp70 to perform protein quality control, one of the possible scenarios might be that HSP70 is targeted by E6AP after the substrates have depleted. In the AS mouse model used in this study, Ube3a was knocked out; this might result in the accumulation of HSP70 after the target substrates have depleted. Ube3a may be acting in the positive feedback system, by promoting the degradation of HSP70 when HSP70 exceeds its threshold level in the body. The loss of Ube3a in knockout mice may prolong the half-life of Hsp70. As other studies have suggested, Hsp70 normally assists in multi-ubiquitin chain ubiquitination at lysine48 (K48), and such ubiquitination normally leads to the degradation of the protein (25) . Even though there are other E3-ligases, all E3-ligases have their own specific targets. In addition, different post-translational modifications by Ube3a may have different effects on the protein and influence the range of functions that it performs (26) . Lack of Ube3a may not only affect the half-life of Hsp70 but also affect the functions of Hsp70.
It is possible that Hsp70 might play a role in cell protection. In Ube3a knockout mice, there may be accumulation of other proteins that are specific substrates of Ube3a for degradation. Elevated levels of HSP70 may be triggered by accumulation of the substrate proteins or misfolded proteins. Studies have shown that elevated levels of HSP70 may assist in unfolding the misfolded proteins to prevent them from becoming toxins in the brain (27) (28) (29) (30) (31) . This may also be the reason that protein aggregates commonly seen in other neurodegenerative diseases are absent in AS mouse models and AS patients. It is generally known that overexpression of HSP70 prior to neuronal insult improves cell survival in both stroke and epilepsy models. However according to recent studies, the neuroprotection effect from the expression of HSP70 in other neurodegenerative diseases was not observed in epileptogenic states, and over-expression of HSP70 in such cases only served as an indicator of neuronal stress in the acute phase of epilepsy (27) . However, other studies have suggested that the death of neuronal cells is not caused by protein aggregation in the brain, but rather by the soluble intermediates. Accumulation of HSP70 may prevent the formation of protein aggregation but allow soluble intermediates to cause toxic effects in AS patients. Both soluble intermediates and protein aggregates attribute to the clinical features of neurodegenerative diseases (32) .
Expression of VDR is found to be reduced in Ube3a knockout mice at the protein level in this 2-D DIGE/MS study. We have also examined the mRNA level of VDR in the cerebellum and hippocampus of Ube3a knockout mice, and it is found to be down-regulated by 55% and 72%, respectively. Its ligand, vitamin-D 3 , controls calcium homeostasis, bone formation, cell differentiation and apoptosis (33, 34) . The down-regulation of VDR may affect calcium homeostasis in mutant mice, as epilepsy is highly correlated with the disruption of calcium levels in cells and is one of the most well-known characteristics observed in Angelman syndrome patients. VDR is a transcriptional regulator that interacts with specific DNA sequences composed of hexanucleotide direct repeats and binds as either a homodimer or heterodimer with retinoid X receptors (RXRs); cell cycle inhibitors p21 and p27 are two known genes that VDR regulates (35, 36) . If VDR is down-regulated in Ube3a knockout mice, its upstream regulator BAG1L may also be affected. BAG1L, along with BAG1, BAG1M (Rap46), and BAG1S, are four protein isomers that the human BAG1 gene encodes. Recently, Hsp70 has been identified as a partner of BAGL1 in enhancing the trans-activation function of VDR in a concentration-dependent manner; this interaction has been speculated to improve tumor cell responses (37, 38) . Since BAG1L couples with Hsp70 to perform its functions, the accumulation of Hsp70 detected in the AS mouse model may be related to the down-regulation of VDR. VDR is a multifunctional protein that is known to regulate calcium homeostasis (33, 34) and immunity (39) . Therefore, the correlation between BAG1L, accumulation of Hsp70 and down-regulation VDR may be an interesting area to study in the Ube3a knockout model.
The homeostasis of Ca 2+ in neurons can be achieved by the transportation of Ca 2+ across the membrane, sequestration by cellular organelles, or with cytosolic buffering proteins such as pavalbumin and CaBP. Calcium ions, in turn, are actively involved in signal transduction, the development of regulatory proteins that modulate calcium ion transients, neurogenesis and many other functions. Lack of cytoplasmic CaBP severely impairs Ca 2+ homeostasis and causes nerve cells to be selectively vulnerable to Ca 2+ related injury (40, 41) . In the 2-D DIGE/MS study and Western blot analysis, CaBP was one of the proteins that was downregulated in both cerebellum and hippocampus tissue of Ube3a knockout mice. It is known that the decline of CaBP in hippocampal dentate granule cells correlates with the kindling model for epilepsy; this may help to explain the frequent seizures observed among Angelman syndrome patients, as excess levels of intracellular Ca 2+ may disrupt neuronal signal transduction (42) .
Another study has shown that CaBP facilitates neuronal differentiation via up-regulation of genes such as NeuroD, Pax6, VDR and Mash1 in a pathway involving CaMK (14) . Mash1 or ASC1 is one of the basic helix-loop-helix (bHLH) transcription factors that heterodimerizes with the ubiquitous Class I bHLH E proteins to form complexes that are crucial in neurogenesis and neural differentiation during development (43) . Adult neural progenitor cells continue to generate new neurons, astrocytes and oligodendrocytes in the brain throughout life, under normal turnover circumstances, or after ischemia in status epilepticus. Mash1 and Olig2 stimulate neurogenenesis and differentiation of progenitor cells in the telencephalon, generating the vast array of neurons and glia cells found in the adult cerebral cortex and giving rise to the ganglionic eminence and olfactory epithelium (44, 45) . A study using Mash1 null mutant mice showed that Mash1 is required for the generation of an early population of oligodendrocyte precursors (OPCs), which is involved in the regulation of synaptic transmission and adult neurogenensis (46) . Mice with a targeted deletion in Mash1 also fail to develop pulmonary neuroendocrine cells (PNECs), and they die in the neonatal period due to respiratory failure (47) . NeuroD or Beta2 is another basic helix loop helix (bHLH) transcription factor expressed in neurons of the cortical plate, as well as neuroendocrine cells in the stomach, gut, pancreas and adult lung (48, 49) . It is involved in the differentiation of neurons and the development of the pancreas, inner ear and retina (48, 50) . Like other bHLH factors, it heterodimerizes with E proteins and controls the transcription of a variety of genes to induce neuron differentiation. When NeuroD is deleted in mice, the early differentiating pancreatic endocrine cells die, and total pancreatic insulin level is only about 5% of normal level. The mutant mice will eventually die within five days after birth due to hyperglycemia. In the hippocampus of NeuroD null mice, when the granule cells reach the dentate gyrus, both cell proliferation and differentiation are severely disturbed, leading to severe cellular depletion in the brain (49) . The hippocampal mRNA and protein levels of CaBP have been demonstrated to express concurrently with the expression of these bHLH transcription factors (14) . In the Real-Time RT-PCR study, fresh tissue from the AS mouse model was used instead of the progenitor cell cultures that were used in the previous study (14) . This was to ensure that the Ube3a knockout environment was retained and was able to reflect the complex activity in vivo. In this case, CaBP mRNA levels were down-regulated by 57% in the cerebellum and 80% in the hippocampus; NeuroD mRNA levels were down-regulated concurrently by 33% and 85% in the cerebellum and hippocampus, respectively. However, Mash1 mRNA levels remained unchanged in the two tissues. NeuroD encoding a bHLH protein is involved in neuronal cells development as well as differentiation; the down-regulation of NeuroD at mRNA levels may implicate the lack of differentiation in dendritic spines observed in the AS mouse model (51) . Even though Mash1 mRNA levels were unaffected, its protein levels were reduced in both the cerebellum and hippocampus of Ube3a knockout mice. On the other hand, NeuroD mRNA was downregulated in the cerebellum and hippocampus, while NeuroD protein was accumulated in the cerebellum and down-regulated in the hippocampus. The deficiency of these two proteins in the hippocampus may not only affect the development and differentiation of cells but also affect neurogenesis after ischemic or neuronal damage.
Vitamin D 3 has been shown to induce the expression of CaBP (52, 53) , and vitamin D 3 receptor (VDR) and CaBP have been found to co-localize in many tissues, especially in the brain. Reduced CaBP and VDR mRNA levels in the hippocampus of neurodegenerative Alzheimer's disease have been reported (54) . This coincides with our findings in the Real Time RT-PCR experiment that CaBP and VDR are down-regulated by 57% and 55%, respectively, in the cerebellum, and down-regulated by 80% and 72%, respectively, in the hippocampus of Ube3a knockout mice. Since both mRNA levels were affected and VDR protein levels were down-regulated in the 2D-DIGE analysis, this might correlate with the CaBP deficiency observed in the cerebellum and hippocampus. These findings demonstrate a specific association between VDR and CaBP.
Reactive oxygen species (ROS) are electronically activated species that have been shown to behave as signal transduction molecules that modulate protein function, such as facilitating oxidative posttranslational modification on protein chaperones (55, 56) . The intrinsic mitochondrial apoptotic pathway is the most common form of cell death in neurodegeneration; it controls the activation of caspase-9 by regulating the release of cytochrome c from the mitochondrial intermembrane space (IMS) (57) . ROS are normal by-products of mitochondrial respiratory chain activity (58) . ROS concentration is mediated by mitochondrial antioxidants such as manganese superoxide dismutase (SOD2) and glutathione peroxidase (59) . Over production of ROS (oxidative stress) is a central feature of all neurodegenerative disorders (60) . In addition to the generation of ROS, mitochondria are also involved in life-sustaining functions, including calcium homeostasis, mitochondrial fission and fusion, lipid concentration of the mitochondrial membranes and mitochondrial permeability transition (56, 57, 61) . It is known that mice lacking SOD2 die several days after birth, amid massive oxidative stress (62) . In our study, we observed that protein levels of SOD2 but not transcriptional levels were downregulated in AS mice. Since SOD2 is vital for handling oxidative stress in mitochondria, down-regulation of SOD2 may cause a surge of oxidative damage in cells and eventually lead to cell death.
Lactate dehydrogenase (LDH), malate dehydrogenase (MDH) and Glutathione Stransferase Mu1 are found differentially expressed in the AS mice. These are proteins that are known to be involved in REDOX reactions. LDH catalyzes the interconversion of pyruvate and lactate with concomitant interconversion of NADH and NAD. Malate dehydrogenase (MDH) is an enzyme in the citric acid cycle that catalyzes the conversion of malate into oxaloacetate by using NAD + . Pyruvate in the mitochondria is acted upon by pyruvate carboxylase to form oxaloacetate, a citric acid cycle intermediate (63, 64) . Glutathione S-transferase (GSTs) families consist of a total of eight sub-classes of isoenzymes, including alpha, kappa, mu, omega, pi, sigma, theta and zeta. These isoenzymes can be cytosolic, mitochondrial, or microsomal proteins depending on the site that they are acting on (65) . Glutathione S-transferase Mu1 (GSTM1) is a human glutathione S-transferase. The mu class of enzymes functions mainly in the detoxification of electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins and products of oxidative stress, by conjugation with glutathione (GST) (66) . Genetic variations of GSTM1 can change an individual's susceptibility to carcinogens and toxins, as well as affect the toxicity and efficacy of certain drugs. GSTM1 is essential for cell protection as reports show that GSTM1 null mice are predisposed to increased cancer risk due to increased susceptibility to environmental toxins and carcinogens (65, 67, 68) . When SOD2, LDH, MDH and GSTs class mu1 are reduced in Ube3a knockout mice, mitochondrial defects are likely to occur, which may lead to neurodegeneration. Mitochondrial dysfunction and oxidative stress are implicated in the pathogenesis of neurodegenerative disease, which includes Alzheimer's disease, Parkinson's disease, Huntington's disease and Amyotrophic lateral sclerosis (ALS) (60, 69) . In the case of ALS, there are several proteins reported to have changes in expression that coincide with the Ube3a knockout mice used in this study; those proteins include ATP synthase, mitochondrial F1 complex subunit; glutathione S-transferase class Mu1 and heat shock 70-kda protein (55) . Intriguingly, in parkin knockout mice, a similar set of proteins is found to be differentially expressed in the cortex and striatum, including ATP synthase chain mitochondrial, lactate dehydrogenase, malate dehydrogenase, stress-70 protein, glutathione S-transferase P2 and N-ethylmaleimide-sensitive fusion protein (70) . In the current study, protein levels of ATP synthase chain mitochondrial, lactate dehydrogenase, malate dehydrogenase, stress-70 protein, glutathione S-transferase class Mu1, and N-ethylmaleimide-sensitive fusion protein are found to be differentially expressed in the AS mice. The mRNA levels of these proteins remained steady in mutant mice, except for LDH, which had a 55% down-regulation of mRNA levels, and glutathione S-transferase class Mu1, which had a 100% up-regulation of mRNA levels in the hippocampus. This showed that most of the proteins involved in REDOX are affected at the translational or protein level in the absence of functional Ube3a, thus suggesting that down-regulation of LDH, MDH and glutathione S-transferase class Mu1 at the protein level may play a crucial role in the pathogenesis of AS.
NSF is not affected at the transcriptional level in the cerebellum and hippocampus of Ube3a knockout mice, but it is specifically affected at the protein level. NSF is up-regulated in the cerebellum but down-regulated in the hippocampus of AS mice. NSF protein is thought to be involved in the docking and fusion of synaptic vesicles at the plasma membrane. It is known that transportation of neurotransmitters at the synapse, which involves synaptic vesicles fusing with the pre-synaptic membrane, relies on such processes to perform neuronal function. Studies have also shown that mutation of NSF in Drosophila can result in coma, presumably because neuronal functions have been blocked in the absence of NSF (71) . AS patients exhibit symptoms such as tremor, ataxia and motor incoordination; a study has also shown motor dysfunction in Ube3a knockout mice (7) . Since NSF is expressed abundantly in the hippocampus under normal circumstances (72) , it is of interest to study the relationship between NSF deficiency in the hippocampus and movement incoordination in mutant mice. NSF has also been discovered as an epilepsy gene (73, 74) . Along with the discovery of CaBP deficiency in Ube3a knockout mice, these two proteins are crucial to the study of clinical features such as inducible seizures that are commonly found in AS patients.
In this study, we used the proteomic approach to study the effects of Ube3a deficiencies. Our results unveil that multiple proteins involved in redox reactions are affected and suggest that oxidative stress is associated with AS. Our results also indicated that proteins involved in neuronal cell differentiation, learning process, energy production, actin disassembly and likely neuronal signal transduction are affected in AS. Our findings provides clues for identification of therapeutic targets and for understanding of the detailed molecular mechanism of AS and other related neurological disorders.
